Treating type 2 diabetes: moving towards precision medicine
- PMID: 36427948
- DOI: 10.1016/S2589-7500(22)00197-2
Treating type 2 diabetes: moving towards precision medicine
Conflict of interest statement
OHYY declares participation on an advisory board at a Rybelsus Specialist Virtual Consultancy Meeting in 2021. J-YS declares no competing interests.
Comment on
- 
  
  Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study.Lancet Digit Health. 2022 Dec;4(12):e873-e883. doi: 10.1016/S2589-7500(22)00174-1. Lancet Digit Health. 2022. PMID: 36427949
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
